Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Larkin

Showing results (111-120 of 418) with videos related to

Pageof 42
Sort By:
The Lancet. Oncology|January 14, 2016
Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinomaRobert J Motzer, Thomas E Hutson, Min Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2022
Reply to T. Olivier et alJedd D Wolchok, Harriet Kluger, Federico Campigotto, et al.
Cells|February 10, 2021
Malignant Melanoma of the Gastrointestinal Tract: Symptoms, Diagnosis, and Current Treatment OptionsDarina Kohoutova, Dominic Worku, Hala Aziz, et al.
Future Oncology (London, England)|March 30, 2021
Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanomaEmilie Scherrer, Reina Rau, Maria Lorenzi, et al.
BMJ Open|April 22, 2021
Promoting physical health among people with enduring mental illness: a qualitative study of healthcare providers' perspectivesClaire Collins, Pearse Finegan, Marie O'Shea, et al.
BJGP Open|August 6, 2021
GPs' perceptions of their relationship with the pharmaceutical industry: a qualitative studyJames Larkin, Ivana Pericin, Maurice Collins, et al.
The Australasian Journal of Dermatology|July 3, 2021
Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanomaAarthy K Uthayakumar, Emily Rudd, Mariana Noy, et al.
The Lancet. Oncology|September 8, 2018
Immune checkpoint inhibitors and cardiovascular toxicityAlexander R Lyon, Nadia Yousaf, Nicolò M L Battisti, et al.
HRB Open Research|March 29, 2021
Prevalence and predictors of medication non-adherence among patients with multimorbidity: A systematic review protocolLouise Foley, James Larkin, Richard Lombard-Vance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenibRishika Sinha, Kim Edmonds, Julia Newton-Bishop, et al.
Pageof 42

Showing results (111-120 of 418) with videos related to

Sort By:
Pageof 42
The Lancet. Oncology|January 14, 2016
Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinomaRobert J Motzer, Thomas E Hutson, Min Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2022
Reply to T. Olivier et alJedd D Wolchok, Harriet Kluger, Federico Campigotto, et al.
Cells|February 10, 2021
Malignant Melanoma of the Gastrointestinal Tract: Symptoms, Diagnosis, and Current Treatment OptionsDarina Kohoutova, Dominic Worku, Hala Aziz, et al.
Future Oncology (London, England)|March 30, 2021
Systematic literature review for the association of biomarkers with efficacy of anti-PD-1 inhibitors in advanced melanomaEmilie Scherrer, Reina Rau, Maria Lorenzi, et al.
BMJ Open|April 22, 2021
Promoting physical health among people with enduring mental illness: a qualitative study of healthcare providers' perspectivesClaire Collins, Pearse Finegan, Marie O'Shea, et al.
BJGP Open|August 6, 2021
GPs' perceptions of their relationship with the pharmaceutical industry: a qualitative studyJames Larkin, Ivana Pericin, Maurice Collins, et al.
The Australasian Journal of Dermatology|July 3, 2021
Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanomaAarthy K Uthayakumar, Emily Rudd, Mariana Noy, et al.
The Lancet. Oncology|September 8, 2018
Immune checkpoint inhibitors and cardiovascular toxicityAlexander R Lyon, Nadia Yousaf, Nicolò M L Battisti, et al.
HRB Open Research|March 29, 2021
Prevalence and predictors of medication non-adherence among patients with multimorbidity: A systematic review protocolLouise Foley, James Larkin, Richard Lombard-Vance, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenibRishika Sinha, Kim Edmonds, Julia Newton-Bishop, et al.
Pageof 42